Thomas C. Freyman, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 3,362 shares at $54.41 ($184K) on 2009-02-17, disclosed to the SEC on 2009-02-19.
Scheduled sale ($184k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.41 | 100 | $5K | 3.0% |
| 2 | $54.41 | 200 | $11K | 5.9% |
| 3 | $54.41 | 254 | $14K | 7.5% |
| 4 | $54.94 | 2,808 | $154K | 83.7% |
| Total | $54.85 avg | 3,362 | $184K | 100% |
| Filing → |
| TEN | BUY | 2018-08-10 | $222K | — | Filing → |
| ABT | SELL | 2014-03-04 | $117K | — | Filing → |
| TEN | BUY | 2013-05-03 | $57K | — | Filing → |